NCT05021926 - Safety and Performance of DKL Crosslinked Sodium Hyaluronate 26 Dermal Filler for Cheek Augmentation | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

August 30, 2021

Primary Completion Date

January 6, 2023

Study Completion Date

January 6, 2023

Conditions

Aging Problems

Interventions

DEVICE

DKL crosslinked sodium hyaluronate 26

is injected into the midface on Day 1. The volume of injection will not exceed 2 mL per side. If applicable, a touch-up of DKL crosslinked sodium hyaluronate 26 will be injected on Day 30; the volume of injection will not exceed 1 mL per side.

DEVICE

Juvéderm Voluma™ with lidocaine (Allergan, Inc)

is injected into the midface on Day 1. The volume of injection will not exceed 2 mL per side. If applicable, a touch-up of Juvéderm Voluma™ will be injected on Day 30; the volume of injection will not exceed 1 mL per side.

Trial Locations (1)

752 37

CTC Clinical Trial Consultants AB, Uppsala